Thryv Holdings, Inc. (THRY)
After hours:
| Previous Close | 21.99 |
| Open | 22.05 |
| Bid | 22.27 x 200 |
| Ask | 22.36 x 200 |
| Day's Range | 21.84 - 22.51 |
| 52 Week Range | 15.99 - 26.42 |
| Volume | |
| Avg. Volume | 181,703 |
| Market Cap | 799.027M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.50 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.50 |
Business WireNew Survey Data from Thryv Finds 51% of Small Businesses Expect to Use AI by End of 2025
DALLAS, May 15, 2024--Thryv's AI and Small Business survey reveals the advantages AI is bringing to SMBs and the money and time savings they expect to see from using it.
CNW GroupThryv Therapeutics to Present Preclinical Data of SGK1 Inhibition in Models of Drug-Induced QT Prolongation at the 2024 Heart Rhythm Society Meeting
Thryv Therapeutics Inc., a biotechnology company pioneering precision treatment to treat indications including Congenital Long QT Syndrome, atrial fibrillation, and heart failure, today announced a poster presentation of SGK1 inhibition in models of Drug-Induced QT prolongation at the 2024 Heart Rhythm Society meeting in Boston, MA. This presentation will take place on Friday, May 17th, from 10:30 a.m. to 12:30 p.m. ET. The meeting will commence with a presentation by Thryv co-founder and Princi
Insider MonkeyThryv Holdings, Inc. (NASDAQ:THRY) Q1 2024 Earnings Call Transcript
Thryv Holdings, Inc. (NASDAQ:THRY) Q1 2024 Earnings Call Transcript May 4, 2024 Thryv Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Dee and I will be your conference operator today. At this time, […]
